Abstract:Type of funding sources: Public grant(s) – National budget only. Main funding source(s): DFG project no. 288034826—International Research Training Group (IRTG) 2251 Gestational diabetes mellitus (GDM) is linked to an elevated risk of developing cardiovascular diseases (CVD) both for the mother and the baby in later life. Previous studies have identified fatty acid-binding protein 4 (FABP4) as a prime candidate involved in the pathophysiology of GDM. FABP4 is known to promote an inflammatory response and vascular permeability, induce oxidative stress in endothelial cells (ECs), and impair the nitric oxide signaling pathway, thereby promoting endothelial dysfunction. Indeed, women with GDM exhibit elevated blood levels of FABP4, suggesting its potential as a biomarker for endothelial dysfunction and cardiovascular risk assessment in GDM. However, the role that FABP4 plays in the fetal endothelial function remains poorly understood. Thus, our aim is to understand the role of FABP4 in fetal endothelial dysfunction and its regulation to mitigate the impact of GDM on the vasculature. Fetoplacental vessels and primary human umbilical vein endothelial cells (HUVECs) were isolated from placentas and umbilical cords obtained from both normoglycemic (NG) and GDM pregnancies. We also obtained the clinical data from the mothers and collected the cord blood. Total mRNA from HUVECs was used for bulk RNA sequencing to compare gene expression, while gene expression analysis in the vessels was conducted using RT-qPCR. Additionally, NG HUVECs were pooled and cultured under high laminar flow conditions (30 dyn/cm2) or subjected to various treatments, including insulin (5nM), glucose (25mM), simvastatin (10nm), or VEGF-A stimulation. Subsequent RT-qPCRs were performed to analyze the gene expression of several genes of interest. The bulk RNA sequencing data analysis revealed FABP4 as an overexpressed gene in GDM HUVECs compared to NG. Furthermore, the analysis of data through Gene Set Enrichment Analysis provided a list of different gene sets that are enriched in GDM samples. Among these gene sets are pathways or processes implicated in endothelial dysfunction, such as angiogenesis, PI3K/AKT/mTOR signaling, reactive oxygen species pathway, or inflammatory response. In vitro experiments provided evidence for an elevated FABP4 mRNA expression after VEGF treatment of HUVECs. Conversely, both simvastatin treatment and exposure to laminar flow reduced FABP4 mRNA expression and increased eNOS expression, suggesting a potential inhibitory effect of nitric oxide on FABP4. We provided evidence that FABP4 could be involved in fetal GDM-induced endothelial dysfunction. Shear stress and statins might protect the endothelium against the negative impact of FABP4.

Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

Fatty Acid-Binding Protein 4 in Endometrial Epithelium is Involved in Embryonic Implantation.

Increased Expression of Fatty Acid Binding Protein 4 in Preeclamptic Placenta and Its Relevance to Preeclampsia.

Expression and Function of Fatty Acid-Binding Protein 4 in Epithelial Cell of Uterine Endometrium.

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

Associations of Serum Adipocyte Fatty Acid Binding Protein with Body Composition and Fat Distribution in Nondiabetic Chinese Women

Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes

Risk of Gestational Diabetes Mellitus in Relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China

Potential safety implications of fatty acid-binding protein inhibition

A Comprehensive Analysis of a Cohort from the KEDP-Study

FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction

Alterations in Serum Adipocyte Fatty Acid Binding Protein and Retinol Binding Protein-4 in Normal Pregnancy and Preeclampsia.

Progress of animal FABP family genes and their association with fat deposition

Effect of FABP4 on placental trophoblastic immune inflammatory response in patients of hypertensive disorder complicating pregnancy

The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases

Expression Profiles of FABP4 and FABP5 in Breast Cancer: Clinical Implications and Perspectives

FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes

Circulating Adipocyte Fatty Acid Binding Protein (Fabp4) Levels Are Associated With Irisin In The Middle-Aged General Chinese Population

Clinical Implications of Plasma Adipocyte Fatty Acid Binding Protein Levels in Patients with Obesity and Type 2 Diabetes

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Postnatal Expression Pattern of Adipose Type Fatty Acid Binding Protein in Different Adipose Tissues of Porcine